Targeting the NO‐cGMP‐PDE5 pathway in COVID‐19 infection. The DEDALO project
Andrea M. Isidori(Policlinico Umberto I), Gabriella d’Ettorre(Policlinico Umberto I), Daniele Gianfrilli(Sapienza University of Rome), Federica Campolo(Saint Camillus International University of Health and Medical Sciences), Riccardo Pofi(Churchill Hospital), Mary Anna Venneri(Sapienza University of Rome), Andrea Lenzi(Canadian Obesity Network), Claudio Maria Mastroianni(Sapienza University of Rome), Elisa Giannetta(Sapienza University of Rome)
Cited by 64
Related Papers
Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors
|Cancer Cell|2005|1.3k
Complications of Cushing's syndrome: state of the art
|The Lancet Diabetes & Endocrinology|2016|602
Testosterone and Metabolic Syndrome: A Meta-Analysis Study
|The Journal of Sexual Medicine|2010|395
Type 2 diabetes mellitus and testosterone: a meta-analysis study
|International Journal of Andrology|2010|369
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE)
|Journal of Endocrinological Investigation|2019|292